MetLife Investment Management’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $155K | Buy |
40,995
+21,352
| +109% | +$80.5K | ﹤0.01% | 2317 |
|
|
2025
Q1 | $89K | Sell |
19,643
-15,331
| -44% | -$69.5K | ﹤0.01% | 2579 |
|
|
2024
Q4 | $247K | Buy |
34,974
+507
| +1% | +$3.58K | ﹤0.01% | 2193 |
|
|
2024
Q3 | $281K | Hold |
34,467
| – | – | ﹤0.01% | 2104 |
|
|
2024
Q2 | $220K | Buy |
34,467
+7,014
| +26% | +$44.8K | ﹤0.01% | 2179 |
|
|
2024
Q1 | $207K | Hold |
27,453
| – | – | ﹤0.01% | 2188 |
|
|
2023
Q4 | $254K | Hold |
27,453
| – | – | ﹤0.01% | 2097 |
|
|
2023
Q3 | $278K | Hold |
27,453
| – | – | ﹤0.01% | 2003 |
|
|
2023
Q2 | $343K | Hold |
27,453
| – | – | ﹤0.01% | 1937 |
|
|
2023
Q1 | $320K | Hold |
27,453
| – | – | ﹤0.01% | 1914 |
|
|
2022
Q4 | $292K | Hold |
27,453
| – | – | ﹤0.01% | 2008 |
|
|
2022
Q3 | $266K | Hold |
27,453
| – | – | ﹤0.01% | 2108 |
|
|
2022
Q2 | $398K | Hold |
27,453
| – | – | ﹤0.01% | 1826 |
|
|
2022
Q1 | $717K | Buy |
27,453
+9,967
| +57% | +$260K | ﹤0.01% | 1545 |
|
|
2021
Q4 | $693K | Hold |
17,486
| – | – | 0.01% | 1311 |
|
|
2021
Q3 | $874K | Buy |
17,486
+1,339
| +8% | +$67K | 0.01% | 1191 |
|
|
2021
Q2 | $896K | Buy |
16,147
+1,503
| +10% | +$83.4K | 0.01% | 1230 |
|
|
2021
Q1 | $685K | Hold |
14,644
| – | – | 0.01% | 1343 |
|
|
2020
Q4 | $637K | Hold |
14,644
| – | – | 0.01% | 1361 |
|
|
2020
Q3 | $536K | Hold |
14,644
| – | – | 0.01% | 1333 |
|
|
2020
Q2 | $427K | Buy |
14,644
+6,010
| +70% | +$175K | ﹤0.01% | 1467 |
|
|
2020
Q1 | $226K | Buy |
8,634
+4,873
| +130% | +$127K | ﹤0.01% | 1633 |
|
|
2019
Q4 | $131K | Sell |
3,761
-3,228
| -46% | -$112K | ﹤0.01% | 2195 |
|
|
2019
Q3 | $221K | Buy |
+6,989
| New | +$221K | ﹤0.01% | 1888 |
|